Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016
Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005
Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017 Year: 2018
Incidental venous thromboembolism, detected by chance, but still venous thromboembolism Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020 Year: 2020
Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012
Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
Clinical significance of deep venous thrombosis in symptomatic pulmonary embolism Source: International Congress 2017 – Pulmonary embolism Year: 2017
Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing Source: Eur Respir J 2016; 47:1313-1314 Year: 2016
Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007
Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021 Year: 2022
Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002
Therapeutic aspects of pulmonary embolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=25 Year: 2004
Venous thrombo-embolism prophylaxis Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009
Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021
Fever in venous thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005
Efficiency of r-TPA therapy in major venous thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007